top of page

AEGEA Medical Announces U.S. FDA Approval of the AEGEA Vapor System(TM) with Adaptive Vapor Ablation for the Treatment of Menorrhagia

NOV 13, 2017

Learn More

After FDA Clearance Earlier This Year, Durham’s Baebies Lands $10M

OCT 31, 2017

Learn More

CardioNXT Raises $2.1M for Atrial Fibrillation Led by Industry Veterans Bullock and Hawkins

JUNE 1, 2017 

Learn More
New transparent.png
Solas - White - Logo.png

LINKEDIN

Headquarters
412 Georgia Avenue
Suite 201

Chattanooga, TN 37403

Office
8 Davis Drive

RTP, NC 27709

©2020 by Solas BioVentures. 

bottom of page